Capstone Investment Advisors, LLC Pfizer Inc Put Options Transaction History

Capstone Investment Advisors, LLC

$24.9 Billion
Q1 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $1.15 Million - $1.33 Million	44,600 Added 6.25%	757,700 $21 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $2.1 Million - $2.73 Million	80,300 Added 12.69%	713,100 $20.5 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $221,421 - $258,819	6,900 Added 1.1%	632,800 $21 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $2.14 Million - $2.48 Million	59,300 Added 10.47%	625,900 $23 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $2.61 Million - $3.4 Million	66,300 Added 13.25%	566,600 $23.1 Million

Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $1.81 Million - $2.36 Million	43,300 Added 9.47%	500,300 $25.6 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $12.5 Million - $15.3 Million	-286,700 Reduced 38.55%	457,000 $20 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $82.6 Million - $98 Million	-1,775,500 Reduced 70.48%	743,700 $39 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $145 Million - $179 Million	-3,164,200 Reduced 55.67%	2,519,200 $130 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $44.3 Million - $65.7 Million	1,073,000 Added 23.27%	5,683,400 $336 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $25.9 Million - $33.3 Million	659,900 Added 16.7%	4,610,400 $198 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $37.4 Million - $42.4 Million	1,042,300 Added 35.84%	3,950,500 $155 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $17.2 Million - $19.4 Million	514,400 Added 21.49%	2,908,200 $105 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $45.7 Million - $58.1 Million	1,366,300 Added 132.97%	2,393,800 $88.1 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $11.3 Million - $13.3 Million	356,400 Added 53.11%	1,027,500 $37.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $4.07 Million - $4.94 Million	135,200 Added 25.23%	671,100 $21.9 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $28.4 Million - $40.5 Million	-1,049,600 Reduced 66.2%	535,900 $17.5 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $14.8 Million - $16.8 Million	450,100 Added 39.64%	1,585,500 $62.1 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $7.85 Million - $10.2 Million	-241,500 Reduced 17.54%	1,135,400 $40.8 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $11.5 Million - $12.9 Million	310,900 Added 29.17%	1,376,900 $59.6 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $18.3 Million - $20.1 Million	486,900 Added 84.08%	1,066,000 $45.3 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $8.86 Million - $10.1 Million	230,200 Added 65.98%	579,100 $25.3 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $7.83 Million - $9.5 Million	227,100 Added 186.45%	348,900 $15.4 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $3.54 Million - $3.77 Million	107,300 Added 740.0%	121,800 $4.42 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $6,382 - $7,404	200 Added 1.4%	14,500 $515,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $443,300 - $488,345	14,300	14,300 $510,000

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

Vanguard Group Inc Valley Forge, PA

507M
Shares

$14.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

431M
Shares

$12.1 Billion
0.28% of portfolio
State Street Corp Boston, MA

291M
Shares

$8.13 Billion
0.37% of portfolio
Wellington Management Group LLP Boston, MA

178M
Shares

$4.97 Billion
0.89% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

122M
Shares

$3.42 Billion
0.79% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account